Diagnostic News and Research

RSS

LCS Therapeutics collaborates to commercialize patent on method to treat binge eating disorder

LCS Therapeutics announced today that it has entered into a strategic collaboration with Lucerne Biosciences, LLC to commercialize U.S. Patent No. 8,318,813 entitled "Method of Treating Binge Eating Disorder."

26 Dec 2014

AMIC files de novo submission with FDA for Y-90 RadioGel device, seeks Class II reclassification

Advanced Medical Isotope Corporation, a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that it has filed a de novo submission with the Food and Drug Administration for marketing clearance for its patented Y-90 RadioGel(TM) device pursuant to Section 513(f)(2) of the U.S. Food, Drug and Cosmetic Act.

23 Dec 2014

Different gene mutations lead to different features of ASD

People with autism have a wide range of symptoms, with no two people sharing the exact type and severity of behaviors.

23 Dec 2014

Special issue of Technology and Innovation publishes proceedings of annual NAI conference

The current special issue of Technology and Innovation, is devoted to presentations from the Third Annual Conference of the National Academy of Inventors (NAI), which was held Mar. 6-7, 2014, at the headquarters of the United States Patent and Trademark Office (USPTO) in Alexandria, Va.

22 Dec 2014

FDA approves Myriad’s BRACAnalysis CDx for use with ovarian cancer drug

Myriad Genetics, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for BRACAnalysis CDx to be used as the only companion diagnostic in conjunction with AstraZeneca’s drug Lynparza™ (olaparib).

22 Dec 2014

SPECT scan measures brain activity during seizures

Loyola University Medical Center is offering epileptic patients an imaging scan that records brain activity during seizures.

18 Dec 2014

University Hospital Bonn to validate accuracy of VolitionRx’s Nucleosomics technology in lung cancer

VolitionRx Limited, a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced that the University Hospital Bonn in Germany will initiate a clinical confirmatory study to assess VolitionRx’s proprietary Nucleosomics platform technology for the diagnosis of lung cancer through a blood test in individuals.

18 Dec 2014

UCLA researchers develop lens-free microscope that can detect cancer, other cell-level abnormalities

UCLA researchers have developed a lens-free microscope that can be used to detect the presence of cancer or other cell-level abnormalities with the same accuracy as larger and more expensive optical microscopes.

17 Dec 2014

Researchers find new 'sliding scale' model to rule out blood clots in lungs

Researchers from Intermountain Medical Center in Salt Lake City have identified a new "sliding scale" model used to rule out potentially deadly blood clots in the lungs, known as pulmonary embolisms, that is more accurate than current diagnostic methods.

17 Dec 2014

Real-time radiation-exposure feedback can help medical workers adopt safer radiation practices

It's a sound that saves. A "real-time" radiation monitor that alerts by beeping in response to radiation exposure during cardiac-catheterization procedures significantly reduces the amount of exposure that medical workers receive, UT Southwestern Medical Center researchers found.

17 Dec 2014

Bacterial biofilms may increase colon cancer risk

Researchers from Johns Hopkins have found that dense mats of interacting bacteria, called biofilms, were present in the majority of cancers and polyps, particularly those on the right side of the colon. The presence of these bacterial bunches, they say, may represent an increased risk for colon cancer and could form the basis of new diagnostic tests.

17 Dec 2014

Stuttgart scientists reveal current state of research on catalytic micro- and nanomotors

At least since the movie “The Fantastic Voyage” in 1966, in which a submarine is shrunk down and injected into the blood stream of a human, people have been toying with the idea of sending tiny “micromachines” and “nanorobots” into our organs or individual cells to carry out delicate “repairs”.

17 Dec 2014

Study provides new evidence for anti-cirrhotic effects of GENFIT's GFT505

GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces that a recent study provides new evidence for anti-cirrhotic effects of GFT505 in the context of NASH.

17 Dec 2014

ARA 290 drug reduces neuropathic pain in type 2 diabetic patients

Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech company developing novel treatments for chronic diseases, investigators also observed improvements in metabolic control in patients administered ARA 290.

16 Dec 2014

Roche announces launch of cobas Liat System for on-demand testing in different settings

Roche today announced the launch of the cobas Liat System—a fast, compact , easy to use, molecular diagnostic platform, designed for on-demand testing in physician clinics, pharmacies and hospital lab settings.

16 Dec 2014

New MIT study implicates RNA-binding proteins in regulation of cancer

A new study from MIT implicates a family of RNA-binding proteins in the regulation of cancer, particularly in a subtype of breast cancer. These proteins, known as Musashi proteins, can force cells into a state associated with increased proliferation.

16 Dec 2014

Photoacoustic imaging has potential to be used as noninvasive method to detect cervical cancer

Cervical cancer is, in many ways, a shining example of how successful the war on cancer can be. Thanks largely to the advent of Pap smear screening, U.S. cervical cancer deaths decreased dramatically, by more than 60 percent, between 1955 and 1992. In the last two decades, better treatment outcomes and more powerful imaging techniques have steadily pushed 5-year survival rates ever higher.

15 Dec 2014

Diagnostic News and Research

LCS Therapeutics collaborates to commercialize patent on method to treat binge eating disorder

AMIC files de novo submission with FDA for Y-90 RadioGel device, seeks Class II reclassification

Different gene mutations lead to different features of ASD

Special issue of Technology and Innovation publishes proceedings of annual NAI conference

FDA approves Myriad’s BRACAnalysis CDx for use with ovarian cancer drug

SPECT scan measures brain activity during seizures

University Hospital Bonn to validate accuracy of VolitionRx’s Nucleosomics technology in lung cancer

UCLA researchers develop lens-free microscope that can detect cancer, other cell-level abnormalities

Researchers find new 'sliding scale' model to rule out blood clots in lungs

Real-time radiation-exposure feedback can help medical workers adopt safer radiation practices

Bacterial biofilms may increase colon cancer risk

Stuttgart scientists reveal current state of research on catalytic micro- and nanomotors

Study provides new evidence for anti-cirrhotic effects of GENFIT's GFT505

ARA 290 drug reduces neuropathic pain in type 2 diabetic patients

Roche announces launch of cobas Liat System for on-demand testing in different settings

New MIT study implicates RNA-binding proteins in regulation of cancer

Photoacoustic imaging has potential to be used as noninvasive method to detect cervical cancer

FSH acquires VERION Image Guided System, LenSx Laser surgical technology

Endomagnetics reveals new brand identity Endomag

Revolutionising back pain treatments: an interview with Dr Kieran O’Sullivan

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News